As-needed Dual Inhaled Corticosteroid-Formoterol in Mild Asthma: Scientific Evidence

Arch Bronconeumol. 2024 Apr;60(4):197-199. doi: 10.1016/j.arbres.2024.01.003. Epub 2024 Jan 17.

[Article in English, Spanish]

Authors

Richard Beasley¹, Diogenes S Ferreira², Alberto Papi³

Affiliations

¹ Medical Research Institute of New Zealand, Wellington, New Zealand. Electronic address: [email protected].
² Private Practice, Allergy and Immunology, Belo Horizonte, Brazil.
³ University of Ferrara, Ferrara, Italy.

PMID: 38326118
DOI: 10.1016/j.arbres.2024.01.003

No abstract available

Publication types

Editorial

MeSH terms

Administration, Inhalation
Adrenal Cortex Hormones / therapeutic use
Anti-Asthmatic Agents* / therapeutic use
Asthma* / drug therapy
Bronchodilator Agents / therapeutic use
Ethanolamines / therapeutic use
Formoterol Fumarate / therapeutic use
Humans

Substances

Formoterol Fumarate
Bronchodilator Agents
Adrenal Cortex Hormones
Ethanolamines
Anti-Asthmatic Agents